SENNOSIDE 8.6MG tablet, film coated

Sennoside 8.6mg by

Drug Labeling and Warnings

Sennoside 8.6mg by is a Otc medication manufactured, distributed, or labeled by Strive Pharmaceuticals Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Sennoside 8.6mg

INACTIVE INGREDIENT

croscarmellose sodium, dibasic calcium phosphate, hydroxypropyl methyl cellulose, magnesium stearate, polyethylene glycol

DOSAGE & ADMINISTRATION

• do not take more than directed
• take with full glass of water
• take preferably at bedtime or as directed by a doctor

Age	Starting dosage	Maximum dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablets twice a day
children 6 to under 12 years	1 tablet once a day	2 tablets twice a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

INDICATIONS & USAGE

• relieves occasional constipation (irregularity)
• generally causes a bowel movement in 6-12 hours

WARNINGS

Do not use

laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

• stomach pain
• nausea
• vomiting
• notice a sudden change in bowel habits that continue over a period of 2 weeks

Stop use and ask a doctor if

you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.

If pregnant or breast-feeding

ask a health professional before use

Keep out of reach of children

Overdose Warning: In case of accidental overdose, get medical help or contact a Poison Control Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms

KEEP OUT OF REACH OF CHILDREN

Keep out of reach of children

Incase of accidental overdose, get medical help or contact a Poison Contril Center right away. Prompt medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.

PURPOSE

Laxative

OTHER SAFETY INFORMATION

• Store at room temperature between 20 ºC - 25 ºC (68 ºF - 77 ºF).

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

SENNOSIDE 8.6MG 
sennoside 8.6mg tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70692-112
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN)	SENNOSIDES A AND B	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
MAGNESIUM STEARATE (UNII: 70097M6I30)
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
HYPROMELLOSES (UNII: 3NXW29V3WO)

Product Characteristics
Color	gray	Score	no score
Shape	ROUND (BICONVEX)	Size	5mm
Flavor		Imprint Code	S3
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70692-112-41	4 in 1 PACKAGE; Type 0: Not a Combination Product	12/20/2018

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	12/20/2018

Labeler - Strive Pharmaceuticals Inc. (080028013)